Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation
- PMID: 36776218
- PMCID: PMC9910956
- DOI: 10.3389/adar.2022.10550
Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation
Abstract
Cannabinoids and the endocannabinoid system have been well established to play a crucial role in the regulation of the immune response. Also, emerging data from numerous investigations unravel the imperative role of gut microbiota and their metabolites in the maintenance of immune homeostasis and gut barrier integrity. In this review, we concisely report the immunosuppressive mechanisms triggered by cannabinoids, and how they are closely associated with the alterations in the gut microbiome and metabolome following exposure to endogenous or exogenous cannabinoids. We discuss how cannabinoid-mediated induction of microbial secondary bile acids, short chain fatty acids, and indole metabolites, produced in the gut, can suppress inflammation even in distal organs. While clearly, more clinical studies are necessary to establish the cross talk between exo- or endocannabinoid system with the gut microbiome and the immune system, the current evidence opens a new avenue of cannabinoid-gut-microbiota-based therapeutics to regulate immunological disorders.
Keywords: cannabinoids; drug abuse; endocannabinoids; inflammation; microbiota.
Conflict of interest statement
CONFLICT OF INTEREST The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1. J Autoimmun. 2018. PMID: 29861127 Review.
-
Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.Front Immunol. 2021 May 26;12:658354. doi: 10.3389/fimmu.2021.658354. eCollection 2021. Front Immunol. 2021. PMID: 34122415 Free PMC article. Review.
-
Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis.Microbiome. 2021 Sep 7;9(1):183. doi: 10.1186/s40168-021-01137-3. Microbiome. 2021. PMID: 34493329 Free PMC article.
-
Regulation of Immune Homeostasis, Inflammation, and HIV Persistence by the Microbiome, Short-Chain Fatty Acids, and Bile Acids.Annu Rev Virol. 2023 Sep 29;10(1):397-422. doi: 10.1146/annurev-virology-040323-082822. Annu Rev Virol. 2023. PMID: 37774124 Review.
-
High and Mighty? Cannabinoids and the microbiome in pain.Neurobiol Pain. 2021 Feb 16;9:100061. doi: 10.1016/j.ynpai.2021.100061. eCollection 2021 Jan-Jul. Neurobiol Pain. 2021. PMID: 33665479 Free PMC article.
Cited by
-
Emerging mechanisms by which endocannabinoids and their derivatives modulate bacterial populations within the gut microbiome.Adv Drug Alcohol Res. 2023 Dec 8;3:11359. doi: 10.3389/adar.2023.11359. eCollection 2023. Adv Drug Alcohol Res. 2023. PMID: 38389811 Free PMC article. Review.
-
Development of Delivery Systems with Prebiotic and Neuroprotective Potential of Industrial-Grade Cannabis sativa L.Molecules. 2024 Jul 29;29(15):3574. doi: 10.3390/molecules29153574. Molecules. 2024. PMID: 39124978 Free PMC article.
-
Limited Impact of Cannabidiol on Health-related Quality of Life of People With Long-term Controlled HIV: A Double-blind, Randomized, Controlled Trial.Open Forum Infect Dis. 2024 Aug 27;11(9):ofae492. doi: 10.1093/ofid/ofae492. eCollection 2024 Sep. Open Forum Infect Dis. 2024. PMID: 39296339 Free PMC article. Clinical Trial.
-
Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma.ACS Pharmacol Transl Sci. 2025 Mar 26;8(4):932-950. doi: 10.1021/acsptsci.4c00583. eCollection 2025 Apr 11. ACS Pharmacol Transl Sci. 2025. PMID: 40242585 Review.
-
Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism.Acta Pharmacol Sin. 2025 Jun;46(6):1676-1691. doi: 10.1038/s41401-025-01495-w. Epub 2025 Feb 20. Acta Pharmacol Sin. 2025. PMID: 39979552 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources